This Moderna Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

Moderna
Enbridge Inc.
Evolution Petroleum Corporation

Moderna

MRNA

0.00

Enbridge Inc.

ENB

0.00

Evolution Petroleum Corporation

EPM

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Argus Research analyst John Eade upgraded Moderna Inc (NASDAQ:MRNA) from Hold to Buy and announced a $180 price target. Moderna closed at $142.77 on Thursday. See how other analysts view this stock.
  • Northland Capital Markets analyst Jeff Grampp upgraded Evolution Petroleum Corporation (AMEX:EPM) from Market Perform to Outperform and announced a $4 price target. Evolution Petroleum shares closed at $3.58 on Thursday. See how other analysts view this stock.
  • CIBC analyst Robert Catellier upgraded Enbridge (TSX:ENB) from Neutral to Outperformer and raised the price target from C$77 to C$78. See how other analysts view this stock.

Considering buying MRNA stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.